Showing results (1841-1850 of 4,219) with videos related to

Sort By:
Pageof 422
Discover Oncology|April 18, 2025
Development and validation of nomogram model predicting overall survival and cancer specific survival in glioblastoma patientsYingming Mu, Junchi Luo, Tao Xiong, et al.
Discover Oncology|April 19, 2025
Research progress on ADAM28 in malignant tumorsLanlan Zhao, Wei Liu, Fei Wang
Discover Oncology|April 24, 2025
Knowledge map of programmed cell death in esophageal cancer: a bibliometric analysisRulin Li, Yanchun Yang, Yang Gao, et al.
Discover Oncology|April 17, 2025
The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantationRong-Rong Yao, Quan-Bao Zhang, Meng-Xi Ge, et al.
Discover Oncology|April 17, 2025
Higher density of compact B cell clusters in invasive front may contribute to better prognosis in pancreatic ductal adenocarcinomaJunwen Zhou, Kunping Yang, Mei Lu, et al.
Discover Oncology|April 19, 2025
Advances in the roles and molecular mechanisms of exosomal circular RNAs in regulating the pre-metastatic niche of tumorsWei Xu, Luyu Zhu, Shiqi Zhang, et al.
Discover Oncology|April 6, 2025
The potential of miR-29 in modulating tumor angiogenesis: a comprehensive reviewRui-Ting Zhou, Xiao-Jie Luo, Xiao-Xin-Ran Zhang, et al.
Discover Oncology|April 9, 2025
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targetingFenglin Li, Yao Chen, Haihui Zhuang, et al.
Discover Oncology|April 7, 2025
Causal role of immune cells in thyroid cancer: a two-sample Mendelian randomization studyShurong Wang, Zhouyu Fang, Wenjin Xiao, et al.
Discover Oncology|April 7, 2025
A retrospective study of pembrolizumab plus chemotherapy for head and neck cancer patients: influence of response in combination phase on subsequent maintenance phaseKen Saijo, Hiroo Imai, Yuki Kasahara, et al.
Pageof 422